The Long COVID Strategy

Read Time: 22 Minutes
Clinical Focus: Viral Persistence, Mitochondrial Dysfunction, Microclots

You had a "mild" infection. Three weeks later you could not walk up the stairs. You have brain fog that feels like dementia. You crash after a 20 minute Zoom call. Your standard labs come back normal. Your primary care doctor says it is anxiety. You know it is not.

This is Long COVID. It is real, the mechanisms are increasingly understood, and the standard system has not caught up to the clinical reality. The Long COVID Strategy is the playbook we use with our patients: identify the dominant mechanisms, stabilize the system with pacing and mast cell support, repair the cellular damage, and slowly rebuild capacity. The goal is not to push through. It is to manage through.

What is happening biologically in Long COVID?

Standard medicine often labels Long COVID as deconditioning and prescribes graded exercise. That approach is dangerous for many patients with post-exertional malaise (PEM). The actual mechanisms are several, and they often overlap.

1. Viral Persistence

The virus or its spike protein may still be hiding in tissue reservoirs (gut, lymph, nervous tissue), keeping the immune system in a chronic search and destroy mode. This drains energy at a cellular level and drives ongoing inflammation.

2. Microclots

Tiny fibrin amyloid microclots can form in capillaries. They do not show up on a standard D-Dimer test. They block oxygen delivery to muscle and brain, which is why patients are breathless and fatigued despite normal SpO2 readings on a pulse oximeter.

3. Mitochondrial Dysfunction

The energy producing organelles in your cells get stuck in a defensive state called the Cell Danger Response (CDR). They cannot produce ATP efficiently. The result is profound fatigue that is not improved by sleep.

4. Mast Cell Activation

The viral debris and ongoing inflammation prime mast cells to over-react to small triggers. Many Long COVID patients develop new food sensitivities, flushing, anxiety after eating, and orthostatic intolerance, all hallmarks of mast cell activation.

5. Autonomic Dysfunction (POTS overlap)

A meaningful share of Long COVID patients develop Postural Orthostatic Tachycardia Syndrome (POTS) or related dysautonomia. Heart rate spikes on standing, blood pressure becomes unstable, and basic activities of daily living become exhausting.

{{NEWSLETTER}}

What does the diagnostic workup look like?

We do not chase every possible test. We focus on the patterns most likely to change management.

• Inflammation panel: hs-CRP, ESR, ferritin, fibrinogen.
• Autoimmune screen: ANA, RF, complement levels when indicated.
• Cardiac: ECG, echocardiogram, and a 10 minute lean test for orthostatic intolerance. Holter monitor for inappropriate sinus tachycardia.
• Thyroid and adrenal: Full thyroid panel including reverse T3, AM cortisol, DHEA-S.
• Metabolic: Fasting insulin, A1c, lipid panel, B12, folate, Vitamin D.
• Mast cell screen: Tryptase, 24 hour urine N-methylhistamine and prostaglandin metabolites when indicated.
• Coagulation: D-Dimer (often normal but can be elevated), and selective testing for microclot related markers in research settings.

What is the strategic roadmap for Long COVID treatment?

Phase 1: Crash Landing (Stabilize)

The first job is to stop the spiral. Pushing through makes things worse.

• Strict Pacing: Stay within your "Energy Envelope." Track activity in 30 minute blocks. If you crash, you may set yourself back two to three weeks.
• H1/H2 Blockers: Loratadine or cetirizine in the morning, famotidine twice daily. The goal is to calm mast cells that are over-reacting to viral debris.
• Electrolytes: High sodium intake (3 to 5 grams daily for most patients) to support blood volume. LMNT or Vitassium are practical options. Many Long COVID patients meet criteria for POTS, and volume expansion is foundational.
• Sleep Architecture: Consistent sleep window, dark cool bedroom, magnesium glycinate 400 mg at night. Sleep is when mitochondria repair.

Phase 2: The Reboot (Repair)

Once symptoms are stable and pacing is reliable, we add targeted therapies.

• Low Dose Naltrexone (LDN): 1.5 to 4.5 mg at bedtime, titrated up over weeks. Modulates neuroinflammation and microglial activation in the brain. Often the single most useful medication for brain fog and chronic pain in Long COVID.
• Nattokinase or Serrapeptase: Fibrinolytic enzymes that may help break down microclots. Always under physician supervision because of bleeding risk and interactions with anticoagulants.
• CoQ10 (ubiquinol form) plus PQQ: Mitochondrial support. Typical doses 200 to 400 mg ubiquinol and 10 to 20 mg PQQ daily.
• NAC (N-acetylcysteine): 600 to 1,200 mg daily. Glutathione precursor, supports antioxidant capacity.
• Methylated B vitamins: Particularly methyl-B12 and methylfolate for patients with MTHFR variants and elevated homocysteine.
• Omega-3 (EPA/DHA): 2 to 4 grams daily. Anti-inflammatory and supports membrane repair.

Phase 3: Re-Entry (Movement)

Movement comes last, not first. We start lying down.

• Recumbent only at first: Recumbent bike, rowing machine, swimming. Avoid upright cardio that stresses the autonomic system.
• Heart rate ceiling: Stay in Zone 1 (60 to 70 percent of age predicted maximum). If you spike above the ceiling, you stop and rest.
• Strength before cardio: Brief, low intensity resistance training (light bands, body weight) often tolerated better than aerobic exercise in early recovery.
• Slow progression: Add 10 percent per week if tolerated. Pull back at the first sign of post-exertional malaise.

Actionable Steps for Long COVID Patients

1. Stop pushing. The single most important intervention is strict pacing within your current energy envelope. Track activity in 30 minute blocks.
2. Start the OTC stabilization stack: cetirizine 10 mg in the morning, famotidine 20 mg twice daily, magnesium glycinate 400 mg at night, electrolytes with 1 to 2 grams of sodium daily.
3. Get the right workup ordered: tryptase, full thyroid, hs-CRP, ferritin, fibrinogen, D-Dimer, and a 10 minute lean test.
4. Find a physician who believes you. The single biggest predictor of recovery is having a doctor who treats Long COVID as a real biomedical condition, not a psychiatric one.

Common Questions

Is Long COVID real?

Yes. Long COVID is recognized by the WHO, NIH, and CDC, and it has a defined ICD-10 code (U09.9). The biological mechanisms are increasingly characterized, including viral persistence, microclot formation, mitochondrial dysfunction, and autonomic disruption. Anyone telling you Long COVID is "just anxiety" or "just deconditioning" is behind the literature.

How long does Long COVID last?

The course is highly variable. Many patients improve substantially in 6 to 18 months with appropriate management. A meaningful subset develop chronic illness lasting years. Predictors of slower recovery include severe initial illness, female sex, prior autoimmune or atopic conditions, and ongoing reinfection.

Can I exercise with Long COVID?

Not the way you used to. Graded exercise therapy can be harmful for patients with post-exertional malaise (PEM). The right approach is recumbent, heart rate capped, and progressed only when symptoms allow. We start where the body tolerates and add slowly. Many patients have to start with seated stretching or breathing work before they can do any conventional exercise.

What is post-exertional malaise (PEM)?

PEM is the worsening of symptoms 12 to 48 hours after exertion (physical, cognitive, or emotional). The exertion does not have to be intense. A short walk, a stressful Zoom call, or a social event can trigger a crash that lasts days. PEM is the diagnostic hallmark of myalgic encephalomyelitis (ME/CFS) and a defining feature of severe Long COVID.

What is low dose naltrexone (LDN) and how does it help?

LDN is naltrexone (a medication used for opioid and alcohol use disorder) at a much lower dose (typically 1.5 to 4.5 mg at bedtime versus 50 mg standard). At low doses, it modulates microglial activation and neuroinflammation in the brain. In our practice, LDN is one of the most useful medications for brain fog, fatigue, and chronic pain in Long COVID. It is generic, inexpensive, and well tolerated, but requires compounding pharmacy access.

Are microclots a real thing in Long COVID?

The research evidence for microclot involvement is growing. Specialized imaging and assays show fibrin amyloid microclots in many Long COVID patients. The clinical implication is that some patients benefit from fibrinolytic support (nattokinase, serrapeptase) under supervision, particularly those with persistent breathlessness, brain fog, and exercise intolerance despite normal standard cardiopulmonary workup.

Can I take supplements without seeing a doctor?

The OTC stabilization stack (cetirizine, famotidine, magnesium glycinate, electrolytes) is reasonable to start without a prescription. Beyond that, we recommend working with a physician because the right combination depends on your specific mechanisms, and some supplements (particularly fibrinolytic enzymes) interact with medications and have real risks.

Will I get worse if I get COVID again?

Reinfection can worsen Long COVID symptoms in some patients. We recommend reasonable precautions (vaccination updated, masking in high risk settings, ventilation awareness), but we do not advocate complete isolation, which has its own costs. The right balance is individual.

How is Long COVID different from ME/CFS?

Long COVID and ME/CFS share many features, particularly post-exertional malaise. Many Long COVID patients meet criteria for ME/CFS. The biological mechanisms appear substantially overlapping. The treatment approach is largely the same: pacing, mast cell stabilization, mitochondrial support, autonomic management.

Can pregnancy or perimenopause make Long COVID worse?

Hormonal transitions can worsen Long COVID symptoms. Estrogen withdrawal in perimenopause and the immune shifts of pregnancy and postpartum both interact with the underlying mechanisms. We adjust hormone therapy and monitor closely during these transitions.

Are there clinics that specialize in Long COVID in Philadelphia?

Penn Medicine has a Post-COVID clinic. Jefferson and Temple have programs. These are useful for selected patients but often have long wait times and are limited in scope. Many of our Long COVID patients use Fishtown Medicine as their primary management with referrals to specific specialists when needed.

Will Long COVID show up on standard labs?

Often not. Standard labs are usually normal in Long COVID. The diagnosis is clinical, supported by selected specialty testing. This is why so many patients are dismissed by their primary care doctor or sent to psychiatry.

Deep Questions

How does Fishtown Medicine personalize the Long COVID strategy for individual patients?

We map the dominant mechanisms first. A patient with prominent autonomic dysfunction (POTS overlap) needs a different protocol than a patient with prominent mast cell activation or a patient with prominent post-exertional malaise. We look at the symptom pattern, the lab data, and the lived experience, and we build a sequenced plan that addresses the most disabling mechanisms first. Pacing and stabilization always come before treatment intensification.

What is the role of fibrinolytic therapy and how do you decide who needs it?

Fibrinolytic enzymes (nattokinase, serrapeptase, lumbrokinase) may help dissolve fibrin amyloid microclots associated with Long COVID. We consider them for patients with persistent breathlessness, brain fog, or exercise intolerance despite stabilization of other mechanisms. We screen for bleeding risk, review medication interactions (anticoagulants, antiplatelets, NSAIDs), and start at low doses. We do not recommend fibrinolytic therapy for patients on anticoagulation without explicit coordination with their cardiologist or hematologist.

What is the Cell Danger Response and why does it matter?

The Cell Danger Response (CDR) is a defensive cellular state described by Robert Naviaux in which mitochondria shift from energy production to threat response. The state is adaptive in acute infection. It becomes pathologic when it persists. Long COVID, ME/CFS, fibromyalgia, and other post-viral and chronic fatigue syndromes share this underlying biology. The clinical implication is that mitochondrial support alone is insufficient; we have to identify and address the persistent triggers (viral persistence, ongoing inflammation, autonomic dysfunction) that keep cells locked in CDR.

How do you handle the overlap between Long COVID and POTS?

Many Long COVID patients meet criteria for POTS. We use a 10 minute lean test or formal tilt table to diagnose, then apply the standard POTS toolkit: salt and volume expansion, compression garments, recumbent exercise, and medications when needed (beta blockers, ivabradine, midodrine, fludrocortisone). We coordinate with autonomic neurology or cardiology when complex.

What is the role of antiviral or antiretroviral therapy?

The evidence is emerging. Some research protocols and real world studies suggest that extended courses of antiviral therapy (Paxlovid, ensitrelvir, or extended duration nirmatrelvir-ritonavir) may help patients with viral persistence as the dominant mechanism. The data is preliminary. We discuss this with patients who have severe symptoms, suggestive markers, and who are interested in pursuing investigational protocols. We do not promise outcomes.

How does Long COVID interact with autoimmune disease?

Many Long COVID patients develop new autoimmune phenomena (positive ANA, autoantibodies against beta-adrenergic receptors, M2 muscarinic antibodies). Some develop frank autoimmune disease (thyroiditis, vitiligo, inflammatory arthritis). We screen, monitor, and treat as indicated. For patients with strong autoimmune signals, we may use immunomodulatory approaches (LDN, hydroxychloroquine in select cases) under specialty coordination.

What about hyperbaric oxygen, IV NAD, or other infusion therapies?

The evidence for these therapies is mixed. Hyperbaric oxygen has limited but suggestive data for cognitive symptoms in Long COVID. IV NAD precursor therapy has theoretical mitochondrial support rationale but lacks high quality clinical trial evidence. We approach these therapies as adjuncts for selected patients with adequate financial resources, not as first line treatment. We do not recommend any therapy that requires significant out of pocket expense without a clear rationale and realistic expectations.

How do you support patients who cannot work because of Long COVID?

We help with disability documentation, communicate with employers when needed, and support patients through the SSDI process for those whose impairment is severe and prolonged. We also work with vocational rehabilitation when partial return to work becomes possible. The economic reality of Long COVID is part of the medical conversation.

What is the prognosis for Long COVID?

Variable. Many patients improve substantially in 6 to 18 months. A meaningful subset have ongoing impairment beyond two years. Prognosis is better with early diagnosis, appropriate pacing, and avoidance of repeated reinfection. Prognosis is worse with severe initial illness, ongoing reinfection, and untreated comorbid conditions (sleep apnea, untreated mast cell activation, deconditioning from inappropriate graded exercise).

What is the Warm Invitation Call?

It is a 20 minute video conversation, free, with no commitment. You tell us your story, what has been tried, and what you are looking for. We tell you whether the model fits. If we are not a good fit, we will say so and often help you find a better option.

Scientific References

1. Davis, H. E., et al. (2023). Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21, 133-146.
2. Naviaux, R. K. (2014). Metabolic features of the cell danger response. Mitochondrion, 16, 7-17.
3. Pretorius, E., et al. (2021). Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovascular Diabetology, 20, 172.
4. Bonilla, H., et al. (2023). Therapeutic Trials for Long COVID-19: A Call to Action From the Researchers and Clinicians Treating Patients. Frontiers in Immunology, 14, 1129459.
5. Vernino, S., et al. (2021). Postural tachycardia syndrome (POTS): State of the science and clinical care from a 2019 NIH Expert Consensus Meeting. Autonomic Neuroscience, 235, 102828.

---

Conclusion

You are not broken forever. But you cannot push through this. You have to manage through it.

Book Your Diagnostic. Let's map your recovery.

---

Medical Disclaimer: This resource provides Clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right supplement protocol must be matched to your unique lab work, physiology, and performance goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.